ATLAS fair value
SEK 185.69
Close to fair value · 2% discount
AddLife AB (publ) stock price today, ATLAS forecast and fair value
Healthcare · Medical Instruments & Supplies · Nasdaq Stockholm · Sweden
Prices as of Oct 27, 2026 · SEK
SEK 185.69
Close to fair value · 2% discount
51%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates AddLife AB (publ)'s fair value at about SEK 185.69 per share (reasonable range: SEK 140.65 to SEK 308.25). At SEK 181.30, the stock trades within 8% of that figure: close to fair value.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is high. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives AddLife AB (publ) a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between SEK 173.00 and SEK 190.92; in 9 out of 10, between SEK 158.52 and SEK 208.35. Estimated annual volatility is 25%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. AddLife AB (publ) sits close to fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks ALIF-B.ST has traded between SEK 130.20 and SEK 207.60. Today it is 12.7% below that high and 39% above its low.
On the business: net margin is 6.0%; it trades at 34.7 times earnings.
Its beta is 1.52: it tends to move more than the market, both up and down.
AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech.
Want to see everything about AddLife AB (publ)?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About SEK 185.69 per share according to ATLAS (reasonable range: SEK 140.65 to SEK 308.25). With the stock at SEK 181.30, it is close to that value.
51%: close to a coin flip. In half of the simulated outcomes, ALIF-B.ST ends the month between SEK 173.00 and SEK 190.92.
AddLife AB (publ)'s market capitalization is SEK 21.4B. Its price-to-earnings (P/E) ratio is 34.7: you pay SEK 34.7 for each SEK 1.00 of yearly earnings.
Yes. ALIF-B.ST's current dividend yield is 0.83% at today's price (SEK 181.30).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy